Eledon Pharmaceuticals, Inc. Restricted Cash, Current
Eledon Pharmaceuticals, Inc. (ELDN) had Restricted Cash, Current of $0 as of 2018-12-31, per its 10-K filed 2019-03-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2019-03-28
- 2018-12-31: Restricted Cash, Current $0.00.
- 2018-09-30: Restricted Cash, Current $0.00.
- 2018-06-30: Restricted Cash, Current $0.00.
- 2018-03-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-28 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 |
| 2017-12-31 | $70.00K 10-K · filed 2019-03-28 |
| 2017-06-30 | $13.00K 10-Q · filed 2017-08-09 |
| 2016-12-31 | $14.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |